Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence von YI ZHANG, SCHNABEL, Catherine A, SCHROEDER, Brock E, JEREVALL, Piiha-Lotta, JANKOWITZ, Rachel C, FORNANDER, Tommy, STAL, Olle, BRUFSKY, Adam M, SGROI, Dennis, ERLANDER, Mark G

Volltext

Abstract P3-15-01: Metastatic breast cancer: A retrospective study of clinical trials versus standard therapy von Sritharan, N, Tuft, M, Rosenzweig, MQ, Jankowitz, RC

Volltext

Abstract P3-06-03: Copy number analysis identifies ESR1 and MDM4 as drivers of progression in invasive lobular breast carcinoma von Atkinson, JM, Cao, L, Basudan, A, Sikora, MJ, Bahreini, A, Tasdemir, N, Jankowitz, RC, McAuliffe, PF, Dabbs, D, Haupt, S, Haupt, Y, Peter Lucas, PC, Lee, AV, Oesterreich, S

Volltext

Abstract P5-04-21: FGFR4 is a novel druggable target for recurrent ER-positive breast cancers von Levine, KM, Ding, K, Priedigkeit, N, Sikora, MJ, Tasdemir, N, Zhu, L, Tseng, GC, Jankowitz, RC, Dabbs, DJ, McAuliffe, PF, Lee, AV, Oesterreich, S

Volltext

Abstract P3-04-02: Differential turnover of estrogen receptor alpha in invasive lobular carcinoma von Sreekumar, S, Levine, K, Sikora, MJ, Boone, D, Dabbs, DJ, Lee, AV, Jankowitz, RC, Oesterreich, S

Volltext

Abstract P4-05-02: Differential regulation of ER protein-turnover in invasive lobular carcinoma cells von Jankowitz, RC, Sreekumar, S, Levine, KM, Meier, C, Sikora, MJ, Basudan, A, Boone, D, Dabbs, DJ, Jacobsen, B, Lee, AV, Oesterreich, S

Volltext

Abstract PD4-09: Combination FGFR4 and ER-targeted therapy for invasive lobular carcinoma von Levine, KM, Chen, J, Sikora, MJ, Tasdemir, N, Priedigkeit, N, Tseng, GC, Puhalla, SL, Jankowitz, RC, Dabbs, DJ, McAuliffe, PF, Lee, AV, Oesterreich, S

Volltext

Abstract PD7-03: Investigating cortactin as a genetic driver of disease progression in invasive lobular carcinoma von Tasdemir, N, Sikora, MJ, Zhu, L, Levine, KM, Scott, J, Basudan, A, Sflomos, G, Sreekumar, S, Bossart, EA, Elishaev, E, Chandran, UR, Tseng, GC, Jankowitz, RC, Dabbs, DJ, McAuliffe, PF, Brisken, C, Davidson, NE, Oesterreich, S

Volltext

Abstract P2-13-03: The impact of neratinib with or without anti-diarrheal prophylaxis on health-related quality of life in HER2+ early-stage breast cancer: Analyses from the ExteNE... von Delaloge, S, Hurvitz, S, Chan, N, Bose, R, Jankowitz, RC, Thirlwell, M, Láng, I, ten Tije, A, Trudeau, M, Osborne, CR, Shen, Z-Z, Lalla, D, Xu, F, Hunt, D, Olek, E, Tripathy, D, Rugo, HS, Chien, J, Chan, A, Barcenas, CH

Volltext

Abstract P3-05-14: A neoadjuvant window trial of endocrine response in women with invasive lobular carcinoma von Jankowitz, RC, McAuliffe, PF, Sikora, MJ, Butler, L, Ahrendt, G, Johnson, R, Diego, E, Bonaventura, M, Puhalla, S, Lembersky, B, Clark, B, Brufsky, A, Kurland, BF, Davidson, NE, Dabbs, DJ, Oesterreich, S

Volltext

OT3-01-06: A Phase 2 Study Investigating the Safety, Efficacy and Surrogate Biomarkers of Response of 5-Azacitidine (5-AZA) and Entinostat (MS-275) in Patients with Advanced Breast... von Connolly, RM, Jankowitz, RC, Andreopoulou, E, Allred, JB, Jeter, SC, Zorzi, J, Adam, BM, Espinoza-Delgado, I, Baylin, SB, Zahnow, CA, Ahuja, N, Davidson, NE, Stearns, V

Volltext